Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Opthea Ltd Director's Dealing 2024

Dec 16, 2024

32698_rns_2024-12-16_81f2db31-7b31-4be0-80dc-59ec240e571f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Opthea Limited

ABN 32 006 340 567

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Lawrence Gozlan
Date of last notice 21 December 2023

Part 1 ‐ Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Montoya Pty Ltd: Lawrence Gozlan is a
majority shareholder.
Date of change 17 December 2024
No. of securities held prior to change 1,877,357 ordinary shares fully paid.
2,000,000 unquoted options to acquire
fully paid ordinary shares at an exercise
price of $4.49, expiring on 11 October
2024, granted under the NED Plan.
2,000,000 unquoted options to acquire
fully paid ordinary shares at an exercise
price of $0.975112, expiring on 15
November 2032, granted under the NED
Plan
500,000 unquoted performance rights to
acquire fully paid ordinary shares at an
exercise price of $nil, expiring on 15
November 2032, granted under the NED
Plan

01/01/2011

Appendix 3Y Page 1

500,000 unquoted options to acquire fully paid ordinary shares at an exercise price of $0.60, expiring on 29 November 2033, granted under the NED Plan

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [408 x 458] intentionally omitted <==

----- Start of picture text -----

Class Ordinary shares
Number acquired 2,000,000 unquoted options
Number disposed 2,000,000 unquoted options
Value/Consideration Nil
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change 1,877,357 ordinary shares fully paid.
2,000,000 unquoted options to acquire
fully paid ordinary shares at an exercise
price of $0.975112, expiring on 15
November 2032, granted under the NED
Plan
500,000 unquoted performance rights to
acquire fully paid ordinary shares at an
exercise price of $nil, expiring on 15
November 2032, granted under the NED
Plan
500,000 unquoted options to acquire fully
paid ordinary shares at an exercise price
of $0.60, expiring on 29 November 2033,
granted under the NED Plan
2,000,000 unquoted options to acquire
fully paid ordinary shares at an exercise
price of $0.655, expiring on 14 November
2034, granted under the NED Plan.
Nature of change Grant of unquoted options pursuant to the
Example: on-market trade, off-market trade, exercise of options, issue NED Plan.
of securities under dividend reinvestment plan, participation in buy-
back
----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

==> picture [408 x 199] intentionally omitted <==

----- Start of picture text -----

Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A
----- End of picture text -----

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
N/A
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
If prior written clearance was provided, on what date was
this provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3